Precigen (PGEN)
(Delayed Data from NSDQ)
$1.41 USD
+0.01 (0.71%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.41 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Precigen, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 63 | 99 | 115 | 100 | 75 |
Receivables | 2 | 14 | 21 | 17 | 26 |
Notes Receivable | 0 | 0 | 0 | 4 | 0 |
Inventories | 0 | 0 | 13 | 11 | 16 |
Other Current Assets | 4 | 5 | 7 | 17 | 117 |
Total Current Assets | 69 | 118 | 157 | 149 | 235 |
Net Property & Equipment | 7 | 7 | 34 | 35 | 61 |
Investments & Advances | 0 | 0 | 49 | 0 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 67 | 81 | 108 | 120 | 132 |
Deposits & Other Assets | 1 | 1 | 1 | 2 | 1 |
Total Assets | 151 | 216 | 360 | 315 | 456 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 2 |
Accounts Payable | 2 | 4 | 5 | 5 | 6 |
Current Portion Long-Term Debt | 0 | 43 | 0 | 0 | 32 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 30 | 23 | 18 | 26 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 6 | 0 | 4 | 17 | 53 |
Total Current Liabilities | 23 | 79 | 35 | 42 | 123 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 4 | 4 | 26 | 26 | 51 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 183 | 172 | 186 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 33 | 90 | 253 | 247 | 384 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 2,085 | 1,998 | 2,023 | 1,887 | 1,752 |
Retained Earnings | -1,964 | -1,869 | -1,916 | -1,823 | -1,653 |
Other Equity | -2 | -3 | 0 | 4 | -27 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 119 | 126 | 107 | 67 | 72 |
Total Liabilities & Shareholder's Equity | 151 | 216 | 360 | 315 | 456 |
Total Common Equity | 119 | 126 | 107 | 67 | 72 |
Shares Outstanding | 248.90 | 251.00 | 206.70 | 185.40 | 162.60 |
Book Value Per Share | 0.48 | 0.50 | 0.52 | 0.36 | 0.44 |
Fiscal Year End for Precigen, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 63 | 74 | 88 | 118 |
Receivables | NA | 2 | 14 | 14 | 16 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 4 | 5 | 3 | 4 |
Total Current Assets | NA | 69 | 93 | 106 | 138 |
Net Property & Equipment | NA | 7 | 7 | 7 | 7 |
Investments & Advances | NA | 0 | 5 | 7 | 7 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 67 | 77 | 80 | 81 |
Deposits & Other Assets | NA | 1 | 1 | 1 | 1 |
Total Assets | NA | 151 | 191 | 208 | 242 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 2 | 3 | 4 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 14 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 14 | 11 | 8 | 28 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 6 | 19 | 19 | 0 |
Total Current Liabilities | NA | 23 | 33 | 31 | 47 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 4 | 4 | 4 | 4 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 33 | 43 | 41 | 57 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 2,085 | 2,083 | 2,080 | 2,078 |
Retained Earnings | NA | -1,964 | -1,931 | -1,912 | -1,891 |
Other Equity | NA | -2 | -4 | -3 | -3 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 119 | 148 | 166 | 184 |
Total Liabilities & Shareholder's Equity | NA | 151 | 191 | 208 | 242 |
Total Common Equity | 0 | 119 | 148 | 166 | 184 |
Shares Outstanding | 248.90 | 248.90 | 255.40 | 255.40 | 255.40 |
Book Value Per Share | 0.00 | 0.48 | 0.58 | 0.65 | 0.72 |